Background
Methods
Participants
N | Proportion of patients per feature (%) | |
---|---|---|
Age at breast cancer diagnosis | ||
<40 | 76 | 38 |
41–60 | 99 | 49 |
>60 | 25 | 13 |
Bilateral breast cancer | ||
Yes | 30 | 15 |
No | 170 | 85 |
Personal history of ovarian cancer | ||
Yes | 12 | 6 |
No | 188 | 94 |
Family history of breast and ovarian cancer | ||
Cancer in 1st or 2nd relative | ||
Breast cancer dx < 60 | 73 | 36.5 |
Ovarian cancer, any age | 11 | 5.5 |
Male breast cancer, any age | ||
Neither | 104 | 52 |
Unknown | 12 | 6 |
Triple negative (TNBC) | ||
Yes | 28 | 14 |
No | 172 | 86 |
Unknown | ||
Tumor hormone receptor status | ||
Estrogen receptor (ER) | ||
Positive | 89 | 45 |
Negative | 70 | 34 |
Unknown | 41 | 21 |
Pogesteron receptor (PR) | ||
Positive | 80 | 40 |
Negative | 77 | 39 |
Unknown | 43 | 21 |
Her2/neu | ||
Positive | 82 | 41 |
Negative | 60 | 30 |
Unknown | 58 | 29 |
Stage | ||
1 | 48 | 24 |
2 | 103 | 51.5 |
3 | 15 | 7.5 |
4 | 1 | 0.5 |
Unknown | 33 | 16.5 |
Grade | ||
I | 6 | 3 |
II | 70 | 35 |
III | 34 | 17 |
Unknown | 90 | 45 |
All patients | 200 | 100 % |
Genetic analysis
In silico analysis of sequence variants
Results
Exon | HGVS nomenclature | BIC nomenclature | Protein nomenclature | Functional domain | Mutation type | Times observed |
---|---|---|---|---|---|---|
BRCA1 | ||||||
5 | c.181 T > G | C61G | p.Cys61Gly | Ring finger | Missense | 2 |
8 | c.464delA | 583delA | p.Gln155fs | - | Frameshift | 1 |
15 | c.4603G > T | E1535X | p.Glu1535Ter | AD1 | Nonsense | 1 |
17 | c.5030_5033delCTAA | 5149del4 | p.Thr1677_Asn1678delinsIlefs | BRCT1/AD2 | Frameshift | 1 |
20 | c.5263_5264insC | 5382insC | p.Ser1755delinsSerProfs | linker | Frameshift | 22 |
22 | c.5397_5403delCCCTTGG | 5515del7 | p.Thr1799delins | BRCT2/AD2 | Frameshift | 1 |
BRCA2 | ||||||
11 | c.5718_5719delCT | 5946delCT | p.Asn1906_Ser1907 = fs | - | Frameshift | 1 |
11 | c.5851_5854delAGTT | 6079del4 | p.Ser1951_Leu1952delinsTrpfs | - | Frameshift | 2 |
11 | c.5946delT | 6174delT | p.Ser1982Argfs | BRC repeat7 | Frameshift | 1 |
17 | c.7910_7914delCCTTT | 8138del5 | p.Ala2637_Phe2638delinsAlafs | Helical Domain | Frameshift | 1 |
20 | c.8532_8533delAA | 8760delAA | p.Glu2844fs | Tower | Frameshift | 1 |
23 | c.9098_9099insA | 9326insA | p.Thr3033delinsThrSerfs | OB2 | Frameshift | 4 |
27 | c.9682delA | 9908delA | p.Gln3227fs | - | Frameshift | 1 |
BRCA1 mutations
BC№ | HGVS nomenclature | Diagnosis and age of onset | ER | PR | HER2 | TNM | Grade | Stage | Other cancer in patient (age of onset) | Family history of cancer and age of diagnosis |
---|---|---|---|---|---|---|---|---|---|---|
3 | c.5263_5264insC | BC (36) | NA | NA | NA | NA | NA | NA | DC (41) | Grandmother - BC (NA) |
6 | c.5263_5264insC | IDC (43) | - | 1+ | NA | pT2N0Mx | NA | II | OC (45) | Mother – BC (50), sister - BBC (42/53), grandmother – BC and OC (50) |
7 | c.5263_5264insC | BBC (42) | 3+/− | 3+/− | 1+/1+ | pT1N0M0/pT1bpN1M0 | G2/G2 | I/IIB | Grandmother - BC (76), aunt BC(81), father seminoma (NA), cousin with cancer of the oral cavity (NA) | |
17 | c.5263_5264insC | IDC (34) | 2+ | 2+ | NA | NA | G2 | NA | No | |
21 | c.5263_5264insC | IDC (48) | NA | NA | NA | NA | NA | NA | OC (48) | Grandfather - GC (70), grandfather – BT (NA), PC (NA), aunt - CGO (50), cousin - BC (54) |
28 | c.181 T > G | BBC (52/60) | NA | NA | NA | NA | NA | NA | OC (52) | Brother with bone cancer (47) |
37 | c.4603G > T | IDC (37) | - | - | - | pT1cN1M0 | G2 | II | FtC (41) | Grandfather - PC (76), grandfather - LC (69), grandmother - CRC (60) |
39 | c.5263_5264insC | BBC(37/55) | NA/- | NA/- | NA/- | NA | NA | NA | Uncle - PrC (66) | |
73 | c.5263_5264insC | IDLC (53) | - | - | - | pT2pN0M0 | G3 | II | Mother - BC (47) and CRC (71) | |
79 | c.5263_5264insC | IDC (42) | NA | NA | 1+ | NA | NA | NA | Grandmother - GC(70), mother – BBC (27/30), uncle – leukemia (67), grandmother - CLv (75) | |
99 | c.5263_5264insC | IDC (40) | NA | NA | NA | pT1N0M0 | G2 | NA | OC (46) | Grandmother – unknown cancer (>80), mother-CrC (NA), mother’s sister – Paget’s disease of the nipple (NA) |
111 | c.5263_5264insC | ACC (36) | - | - | - | NA | G1 | NA | No | |
121 | c.5263_5264insC | IDC (34) | - | - | - | pT1N0M0 | G3 | I | Father – pelvic cancer (NA), cousin - BC (30) | |
132 | c.181 T > G | IDC (39) | - | - | - | pT1pN0M0 | G2 | I | Grandmother - BC (60), mother -BBC (32/40) | |
134 | c.464delA | IDC (54) | - | - | - | pT1N1M0 | G3 | II | Aunt - BC (47), grandmother and grandmother’s sister - BC(NA), father - LC (NA) | |
140 | c.5263_5264insC | IDC (32) | 1+ | 2+ | 2+ | pT2pN0M0 | G2 | IIa | Mother - BBC (31/37), grandmother - EC, CRC (50/53), grandfather - LC (59), grandmother - BC (NA) | |
142 | c.5263_5264insC | IDC (31) | - | - | - | pT1pN0M0 | G2-3 | I | No | |
143 | c.5263_5264insC | IDC (51) | - | - | - | pT2N0M0 | G3 | I | OC (51) | Uncle - PC (68), grandmother LC (44), cousin - OC (37) |
152 | c.5263_5264insC | BBC (41) | NA | NA | NA | NA | NA | NA | OC (58) | Mother - BBC (NA) |
155 | c.5263_5264insC | BC (29) | - | - | - | NA | NA | NA | Grandmother - BC, ThC (50/70), cousin - BC (50), cousin - OC (48) | |
161 | c.5263_5264insC | IDC (43) | - | - | - | NA | NA | NA | Mother – OC (62) | |
164 | c.5263_5264insC | IDC (45) | - | - | - | NA | NA | NA | Mother - BC (NA) | |
171 | c.5263_5264insC | BC (53) | - | - | - | NA | NA | NA | OC (NA) | Grandmother - BC (43), mother - BC (53) and OC (63) |
175 | c.5263_5264insC | MBC (33) | - | - | - | pT1сN2M0 | G2 | II | No | |
194 | c.5030_5033 | IDC (63) | - | - | - | pT1N0M0 | G2 | NA | No | |
delCTAA | ||||||||||
190 | c.5263_5264insC | IDC (33) | - | - | - | pT1bpN0M0 | G2 | I | Grandmother - BC (47), mother - OC (52), grandfather - CRC (62) | |
204 | c.5263_5264insC | BBC (35/48) | NA | NA | NA | NA | NA | NA | Mother with bladder cancer in doubt | |
205 | c.5397_5403 | IDC (51) | - | - | - | pT1pN1M0 | G3 | II | Grandmother - BC (30), father – PC (NA) | |
delCCCTTGG |
BRCA2 mutations
BC№ | HGVSnomenclature | Diagnosis and age of onset | ER | PR | HER2 | TNM | Grade | Stage | Other cancer in patient | Family history of cancer and age of diagnosis |
---|---|---|---|---|---|---|---|---|---|---|
19 | c.7910_7914 | BBC (31/37) | NA/ NA | NA/ NA | NA/ NA | NA/ NA | NA/ NA | NA | Cousin - BBC (41/49), father - GC (NA), aunt - OC (NA) | |
delCCTTT | ||||||||||
24 | c.9682delA | BBC (52) | NA | NA | NA | NA | NA | NA | NA | |
32 | c.9098_9099insA | IDC (50) | - | - | 3+ | NA | G3 | NA | Aunt – BC (NA) | |
52 | c.5946delT | BBC (41/68) | NA/ | NA/ | NA/ NA | NA/ NA | NA/ NA | NA | OC (59) | Mother - BC (36) sister - BC (46) and CRC (65), father - LC, ethnicity - Jewish |
3+ | 3+ | |||||||||
58 | c.5851_5854 | IDC (48) | 3+ | 3+ | 2+ | pT1N0Mx | G3 | NA | Mother – BC (NA), brother and sister of the mother – CRC (NA), her father – LC (NA), cousin – CRC (NA), a brother of the father – CLv (NA) and his children - BC (35) and - LC (50) | |
delAGTT | ||||||||||
76 | c.5851_5854 | IDLC (53) | - | - | - | pT1pN0M0 | G2 | NA | Cousin - BC (65), father - StC (54) | |
delAGTT | ||||||||||
81 | c.9098_9099insA | BC (59) | NA | NA | NA | NA | NA | NA | Sister - BC (52), aunt - BC (67) | |
85 | c.9098_9099insA | IDC (52) | 3+ | - | - | pT1pN2pMx | G3 | III | Aunt - BC (42), grandfather - head and neck cancer (NA) | |
87 | c.8532_8533 | BBC (30/37) | 3+/ | - | NA | pT1bpN0M0/ | G2/ | I/I | Mother BBC (NA) | |
delAA | 3+ | /3+ | /1+ | pT1bpN0M0 | NA | |||||
88 | c.9098_9099insA | IDLC (61) | - | - | - | pT2pN0M0 | G2-3 | Iia | Grandfather - ThC (48), mother - BC (60), two cousins - BC (34/47) | |
90 | c.5718_5719 | IDC (35) | 2+ | 3+ | 3+ | pT2pN2M0 | G2 | III | Grandfather - LyC (NA), grandmother - unclear malignant disease, most likely melanoma (NA) | |
delCT |
Unclassified variants
Exon | HGVS nomenclature | BIC nomenclature | Protein nomenclature | Functional domain | Mutation type | MAF in Bulgarian patients | Analysed patients (n) | MAF in healthy controls | Analysed healthy controls (n) | MAF in Europeans |
---|---|---|---|---|---|---|---|---|---|---|
BRCA1 | ||||||||||
5 | c.139 T > G | C47G | p.Cys47Gly | ring finger | missense | 0.002 | 200 | 0.000 | 96 | NA |
8 | c.536A > G | Y179C | p.Tyr179Cys | - | missense | 0.002 | 194 | 0.000 | 96 | 0.001 |
11 | c.736 T > G | L246V | p.Leu246Val | - | missense | 0.002 | 200 | - | - | 0.002 |
11 | c. 1067A > G | Q356R | p. Gln356Arg | - | missense | 0.072 | 194 | 0.052 | 96 | 0.049 |
11 | c.1456 T > C | F486L | p.Phe486Leu | - | missense | 0.002 | 200 | - | - | 0.001 |
11 | c.1648A > C | N550H | p.Asn550His | - | missense | 0.002 | 200 | 0.00 | 96 | 0.001 |
11 | c.2077G > A | D693H | p.Asp693Asn | - | missense | 0.065 | 192 | 0.083 | 96 | 0.097 |
11 | c.2612C > T | P871L | p.Pro871Leu | - | missense | 0.350 | 193 | 0.391 | 96 | 0.336 |
11 | c.3113A > G | E1038G | p.Glu1038Gly | - | missense | 0.335 | 195 | 0.349 | 96 | 0.358 |
11 | c.3119G > A | S1040N | p.Ser1040Asn | - | missense | 0.023 | 195 | 0.026 | 96 | 0.580 |
11 | c.3548A > G | K1183R | p.Lys1183Arg | - | missense | 0.339 | 193 | 0.302 | 96 | 0.332 |
11 | c.3999 T > C | V1333A | p. Val1333Ala | AD1 | missense | 0.002 | 200 | 0.00 | 96 | - |
16 | c.4837A > G | S1613C | p.Ser1613Gly | AD2 | missense | 0.323 | 193 | 0.318 | 96 | 0.314 |
16 | c.4956G > A | M1652I | p.Met1652Ile | BRCT1/AD2 | missense | 0.036 | 193 | 0.016 | 96 | 0.005 |
9 | c.591C > T | C197C | p.Cys197= | - | cds-synon | 0.007 | 193 | 0.00 | 96 | 0.001 |
11 | c.2082C > T | S694S | p.Ser694= | - | cds-synon | 0.323 | 192 | 0.318 | 96 | 0.280 |
11 | c.2311 T > C | L771L | p.Leu771= | - | cds-synon | 0.233 | 191 | - | - | 0.332 |
13 | c.4308 T > C | S1436S | p.Ser1436= | AD1 | cds-synon | 0.337 | 194 | - | - | 0.332 |
7 | c.441 + 36_441 + 38delCTT | IVS7 + 36delCTT | - | - | IVS | 0.194 | 195 | 0.354 | 96 | NA |
8 | c.442-34C > T | IVS7-34 C > T | - | - | IVS | 0.230 | 194 | 0.224 | 96 | 0.257 |
9 | c.548-58delT | IVS8-58delT | - | - | IVS | 0.196 | 193 | 0.385 | 96 | 0.331 |
15 | c.4485-63C > G | IVS14-63C > G | - | - | IVS | 0.330 | 197 | - | - | 0.321 |
18 | c.5075-53C > T | IVS17-53 C > T | - | - | IVS | 0.010 | 194 | - | - | 0.034 |
20 | c.5277 + 56delGTA | IVS20 + 56insGTA | - | - | IVS | 0.002 | 200 | 0.00 | 96 | - |
BRCA2 | ||||||||||
10 | c.865A > C | N289H | p.Asn289His | - | missense | 0.050 | 185 | - | - | 0.031 |
10 | c.978C > A | S326R | p.Ser326Arg | - | missense | 0.010 | 185 | - | - | 0.001 |
10 | c.1114A > C | H372N | p.Asn372His | - | missense | 0.283 | 185 | - | - | 0.300 |
11 | c.2971A > G | N991D | p.Asn991Asp | - | missense | 0.050 | 185 | - | - | 0.031 |
11 | c.3515C > T | S1172L | p.Ser1172Leu | - | missense | 0.002 | 185 | 0.00 | 96 | 0.001 |
11 | c.5744C > T | T1915M | p.Thr1915Met | - | missense | 0.017 | 200 | 0.016 | 96 | 0.032 |
11 | c.6100C > T | R2034C | p.Arg2034Cys | - | missense | 0.002 | 200 | - | - | 0.018 |
11 | c.6322C > T | R2108C | p.Arg2108Cys | - | missense | 0.002 | 200 | - | - | 0.001 |
15 | c.7469 T > C | I2490T | p.Ile2490Thr | Helical Domain | missense | 0.002 | 185 | - | - | 0.000 |
23 | c.9104A > C | Y3035S | p.Tyr3035Cys | OB2 | missense | 0.005 | 200 | 0.005 | 96 | NA |
11 | c.4146_4148delAGA | E1382del | delinsAsp | - | Cds_indel | 0.002 | 200 | - | - | NA |
10 | c.1365A > G | S455S | p.Ser455= | - | Cds-synon | 0.030 | 185 | - | - | 0.031 |
11 | c.2229 T > C | H743H | p.His743= | - | Cds-synon | 0.035 | 184 | - | - | 0.031 |
11 | c.3396A > C | K1132K | p.Lys1132= | - | Cds-synon | 0.285 | 182 | - | - | 0.250 |
11 | c.3807 T > C | V1269V | p.Val1269= | - | Cds-synon | 0.189 | 185 | - | - | 0.226 |
14 | c.7242A > G | S2414S | p.Ser2414= | - | Cds-synon | 0.184 | 184 | - | - | 0.190 |
2 | c.-26G > A | 203G > A | - | - | UTR-5 | 0.247 | 190 | - | - | 0.199 |
27 | c.*105A > C | IVS27 + 104A > C | - | - | UTR-3 | 0.183 | 185 | - | - | 0.274 |
4 | c.425 + 67A > C | IVS4 + 67A > C | - | - | IVS | 0.050 | 184 | - | - | 0.031 |
4 | c.425 + 147G > T | IVS4 + 147G > T | - | - | IVS | 0.040 | 184 | - | - | 0.062 |
5_6 | c.426-89 T > C | IVS4-89 T > C | - | - | IVS | 0.040 | 184 | - | - | 0.031 |
8 | c.681 + 56C > T | IVS8 + 56C > T | - | - | IVS | 0.060 | 185 | - | - | 0.133 |
11 | c.6841 + 80_6841 + 83 | IVS11 + 80 | - | - | IVS | 0.289 | 185 | - | - | 0.294 |
delTTAA | delTTAA | |||||||||
13 | c.7007 + 134_7007 + 135 insTTATAAAAT | IVS13 + 164 delTTATAAAAT | - | - | IVS | 0.032 | 186 | - | - | 0.043 |
15 | c.7617 + 28C > A | IVS15 + 28 C > A | - | - | IVS | 0.002 | 200 | - | - | - |
17 | c.7806-14 T > C | IVS16-14 T > C | - | - | IVS | 0.320 | 187 | 0.469 | 96 | 0.465 |
Exon | HGVS nomenclature | BIC nomenclature | BIC | UMD | POLYPHEN2 | SIFT | PROVEAN |
---|---|---|---|---|---|---|---|
BRCA1 | |||||||
5 | c.139 T > G | C47G | unknown | - | probably damaging | damaging | neutral |
8 | c.536A > G | Y179C | unknown | neutral | damaging | tolerated | neutral |
11 | c.736 T > G | L246V | unknown | neutral | probably damaging | tolerated | neutral |
11 | c. 1067A > G | Q356R | unknown | neutral | probably damaging | damaging | deleterious |
11 | c.1456 T > C | F486L | unknown | neutral | benign | tolerated | neutral |
11 | c.1648A > C | N550H | unknown | neutral | probably damaging | damaging | deleterious |
11 | c.2077G > A | D693H | no | neutral | benign | tolerated | deleterious |
11 | c.2612C > T | P871L | no | neutral | benign | tolerated | neutral |
11 | c.3113A > G | E1038G | no | neutral | possibly damaging | damaging | neutral |
11 | c.3119G > A | S1040N | unknown | neutral | probably damaging | damaging | neutral |
11 | c.3548A > G | K1183R | no | neutral | benign | tolerated | neutral |
11 | c. 3999 T > C | V1333A | - | - | possibly damaging | tolerated | neutral |
16 | c.4837A > G | S1613C | no | neutral | benign | damaging | neutral |
16 | c.4956G > A | M1652I | unknown | neutral | benign | tolerated | neutral |
BRCA2 | |||||||
10 | c.865A > C | N289H | no | neutral | benign | tolerated | neutral |
10 | c.978C > A | S326R | no | neutral | benign | tolerated | neutral |
10 | c.1114A > C | H372N | no | neutral | benign | tolerated | neutral |
11 | c.2971A > G | N991D | no | polymorphism | benign | tolerated | neutral |
11 | c.3515C > T | S1172L | unknown | likely neutral | probably damaging | damaging | deleterious |
11 | c.5744C > T | T1915M | no | neutral | benign | tolerated | neutral |
11 | c.6100C > T | R2034C | unknown | neutral | probably damaging | tolerated | deleterious |
11 | c.6322C > T | R2108C | unknown | UV | benign | tolerated | neutral |
15 | c.7469 T > C | I2490T | no | UV | benign | tolerated | neutral |
23 | c.9104A > C | Y3035S | unknown | UV | benign | damaging | Neutral |